| BAN | Breastfeeding, Antiretrovirals, and Nutrition |
| DolPHIN 2 | Dolutegravir in Pregnant HIV Women and Their Neonates |
| EUROCAT | European Surveillance of Congenital Anomalies and Twins |
| EPPICC | European Pregnancy Paediatric HIV Cohort Collaboration |
| HPTN | HIV Prevention Trials Network |
| IMPAACT | International Maternal Pediatric Adolescent AIDS Clinical Trials |
| MOTIVATE | Mother–Infant Visit Adherence and Treatment Engagement |
| PACTG | Pediatric AIDS Clinical Trials Group |
| PANNA | Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women |
| PARTNER | Partners of People on ART-A New Evaluation of the Risks |
| PHACS | Pediatric HIV/AIDS Cohort Study |
| PROMISE | Promoting Maternal and Infant Survival Everywhere |
| SMARTT | Surveillance Monitoring for ART Toxicities |
| START | Strategic Timing of AntiRetroviral Treatment |
| VESTED | Virologic Efficacy and Safety of ART Combinations with TAF/TDF, EFV, and DTG |
